What is an example of a low-dose inhaled corticosteroid (ICS) combined with formoterol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Low-Dose ICS-Formoterol Examples

The most common example of low-dose ICS-formoterol is budesonide-formoterol 100-200 mcg/4.5-6 mcg per inhalation, taken as 1-2 puffs as needed for symptom relief. 1

Specific Formulations

Based on current asthma management guidelines, low-dose ICS-formoterol combinations include:

  • Budesonide-formoterol: 100 mcg budesonide + 4.5-6 mcg formoterol per inhalation 1, 2
  • Beclomethasone-formoterol: Low-dose formulations (specific dosing varies by product) 3

Clinical Context and Dosing

The 2020 NAEPP guidelines specifically recommend low-dose ICS-formoterol 1-2 puffs as needed for:

  • Step 3 asthma management in patients aged 12+ years as both maintenance and reliever therapy 1
  • Quick-relief medication with a maximum total daily dose of 8 puffs (36 mcg formoterol) 1

Key Dosing Parameters

Low-dose ICS-formoterol is administered:

  • Twice daily for maintenance therapy (morning and evening, approximately 12 hours apart) 4
  • As-needed for symptom relief in the single maintenance and reliever therapy (SMART) regimen 1, 3
  • Total daily dose should not exceed the equivalent of 40 mcg formoterol 4

Important Clinical Considerations

This combination should NOT be used in asthma without an inhaled corticosteroid component - formoterol alone (LABA monotherapy) is contraindicated in asthma due to increased risk of asthma-related death, hospitalization, and intubation 4. The ICS component is essential for safety.

The budesonide-formoterol combination at 100 mcg/4.5 mcg twice daily has been shown in clinical trials to reduce severe exacerbations by 60% in corticosteroid-naive patients and by 43% when added to existing ICS therapy 2.

Storage and Handling

Formoterol-containing products require specific storage:

  • Refrigeration at 36-46°F (2-8°C) in protective foil pouch 4
  • May be stored at room temperature (68-77°F) for up to 3 months 4
  • Must be colorless; discard if discolored 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.